Several important techniques are already in use to check for cross-reactivity, including in vitro screening of CD4 and CD8 T cells transduced with tumor-specific TCRs, using as antigen-presenting cells various lines derived from normal tissues. This evidence concerns the gene CD8A and neoplasm.